Nasdaq:gild articles
-
Vise Technologies Inc. Purchases 2,127 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Vise Technologies Inc. increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,497 shares of the biopharmaceutical company’s stock after acquiring an additional 2,127 shares during the period. Vise Technologies […]
-
Enphase Energy (NASDAQ:ENPH), Canadian Solar (NASDAQ
Canadian Solar, Inc. (NASDAQ: CSIQ) reported first-quarter 2024 earnings of 19 cents per share, which surpassed the Zacks Consensus Estimate of a loss of 34 cents. However, the bottom line declined 84% from the first-quarter 2023 reported figure of $1.19 per share. read more
-
Comparing Fractyl Health (NASDAQ:GUTS) and TriSalus Life Sciences (NASDAQ:TLSI)
Fractyl Health (NASDAQ:GUTS – Get Free Report) and TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk. Institutional and Insider Ownership 2.6% of […]